NRG1 and major depressive disorder: Moreover, NRG1 seems to be a predictive biomarker of the response to pharmacological antidepressant treatment as we showed in our analysis of the dataset (GSE32280), that NRG1 changes the expression profile in the MDD patients compared to HCs before and after Venlafaxine treatment.